Abstract

Suicide has high human mortality (0.5-1.2 million death each year). However, it is not well informed and predicable event in the clinic. Early clinical evidence suggests that a large variety of risk factors (external and internal stresses) may drive human neuropsychiatric instability and various suicide behavior and deaths in sufferers and victims. Influenced by different sources of risk factors (individual stresses, genetic cascade and unknown pathogenic consequences), clinical suicide prevention and treatment need ever-growing revolution- -diagnostic and therapeutic transition (genetic study in drug targeting, personalized neuropsychiatric medicine and other sources of emotional supporting) with an unpredictable way. To implement diagnostic and therapeutic transition, bridging the gap between clinical symptoms, molecular profiling, and psychiatric intervene has great medical importance. Currently, neural-psychiatric relation in the realm of integrating various molecular profiling, brain image and suicide behavior has provided profound knowledge and impacts in experimental and clinical investigations. To introduce these system integrations, public health and therapeutic databases should be analyzed. Finally, medical success (neuropsychiatric status, tool access, brain image analysis, molecular targeting, genetic cascade and curative therapies) in the clinic will ensure high-quality pharmaceutical benefits for diathesis-specificity and potential different suffers. Next generation of clinical suicide prediction, pharmacology and therapeutic landscapes will be dawned in the near future.

Keywords

human suicide, neurobiology, nursery, education, psychopharmacology, modern technology, suicide prediction